APO RESEARCH · REPORT
Wilson's Disease
Wilson’s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson’s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson’s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson’s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.
Product & engineering
Understand the product.
Wilson’s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson’s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson’s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson’s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.
Selected research
Industry Research
Wilson's Disease Industry Research Report 2026
Market perspective
Wilson’s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson’s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson’s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson’s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.
The classification of Wilson’s disease includes Trientine, Penicillamine and others, and the proportion of Trientine in 2019 is about 47%. Penicillamine was the first drug approved for the treatment of Wilson’s disease. Penicillamine is the most successful drug used for the treatment of Wilson’s disease. Wilson’s disease is widely used in Hospital, drugs stores and other field. The most proportion of Wilson’s disease is Drugs Store, and the proportion in 2019 is 51%. North America is the largest consumption place, with a consumption market share nearly 76.93% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 10.51%. Market competition is intense. Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, etc. are the leaders of the industry.
Report Scope
Read the full market overview
This report quantifies the global Wilson's Disease market in terms of revenue (US$ million) and, where applicable, service volume (Kg), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Wilson's Disease.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Wilson's Disease Market by Company
Bausch Health
Teva
Endo International
Univar Solutions
MSN Laboratories
ANI Pharmaceuticals
APOTEX
Tsumura
Sinepharm
Taj Pharmaceutical
Kadmon Holdings
Wilson's Disease Segment by Type
Trientine
Penicillamine
Others
Wilson's Disease Segment by Application
Hospital
Drugs Stores
Others
Wilson's Disease Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wilson's Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Wilson's Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wilson's Disease.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Wilson's Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Trientine
- Penicillamine
- Others
Applications
- Hospital
- Drugs Stores
- Others
Companies covered
- Bausch Health
- Teva
- Endo International
- Univar Solutions
- MSN Laboratories
- ANI Pharmaceuticals
- APOTEX
- Tsumura
- Sinepharm
- Taj Pharmaceutical
- Kadmon Holdings
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Wilson's Disease by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Trientine
- 2.2.3 Penicillamine
- 2.2.4 Others
- 2.3 Wilson's Disease by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Drugs Stores
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Wilson's Disease Breakdown Data by Type
- 3.1 Global Wilson's Disease Historic Market Size by Type (2021-2026)
- 3.2 Global Wilson's Disease Forecasted Market Size by Type (2027-2032)
4 Wilson's Disease Breakdown Data by Application
- 4.1 Global Wilson's Disease Historic Market Size by Application (2021-2026)
- 4.2 Global Wilson's Disease Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Wilson's Disease Market Perspective (2021-2032)
- 5.2 Global Wilson's Disease Growth Trends by Region
- 5.2.1 Global Wilson's Disease Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Wilson's Disease Historic Market Size by Region (2021-2026)
- 5.2.3 Wilson's Disease Forecasted Market Size by Region (2027-2032)
- 5.3 Wilson's Disease Market Dynamics
- 5.3.1 Wilson's Disease Industry Trends
- 5.3.2 Wilson's Disease Market Drivers
- 5.3.3 Wilson's Disease Market Challenges
- 5.3.4 Wilson's Disease Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Wilson's Disease Players by Revenue
- 6.1.1 Global Top Wilson's Disease Players by Revenue (2021-2026)
- 6.1.2 Global Wilson's Disease Revenue Market Share by Players (2021-2026)
- 6.2 Global Wilson's Disease Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Wilson's Disease Head Office and Area Served
- 6.4 Global Wilson's Disease Players, Product Type & Application
- 6.5 Global Wilson's Disease Manufacturers Established Date
- 6.6 Global Wilson's Disease Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Wilson's Disease Market Size (2021-2032)
- 7.2 North America Wilson's Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Wilson's Disease Market Size by Country (2021-2026)
- 7.4 North America Wilson's Disease Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Wilson's Disease Market Size (2021-2032)
- 8.2 Europe Wilson's Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Wilson's Disease Market Size by Country (2021-2026)
- 8.4 Europe Wilson's Disease Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Wilson's Disease Market Size (2021-2032)
- 9.2 Asia-Pacific Wilson's Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Wilson's Disease Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Wilson's Disease Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Wilson's Disease Market Size (2021-2032)
- 10.2 South America Wilson's Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Wilson's Disease Market Size by Country (2021-2026)
- 10.4 South America Wilson's Disease Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Wilson's Disease Market Size (2021-2032)
- 11.2 Middle East & Africa Wilson's Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Wilson's Disease Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Wilson's Disease Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Bausch Health
- 12.1.1 Bausch Health Company Information
- 12.1.2 Bausch Health Business Overview
- 12.1.3 Bausch Health Revenue in Wilson's Disease Business (2021-2026)
- 12.1.4 Bausch Health Wilson's Disease Product Portfolio
- 12.1.5 Bausch Health Recent Developments
- 12.2 Teva
- 12.2.1 Teva Company Information
- 12.2.2 Teva Business Overview
- 12.2.3 Teva Revenue in Wilson's Disease Business (2021-2026)
- 12.2.4 Teva Wilson's Disease Product Portfolio
- 12.2.5 Teva Recent Developments
- 12.3 Endo International
- 12.3.1 Endo International Company Information
- 12.3.2 Endo International Business Overview
- 12.3.3 Endo International Revenue in Wilson's Disease Business (2021-2026)
- 12.3.4 Endo International Wilson's Disease Product Portfolio
- 12.3.5 Endo International Recent Developments
- 12.4 Univar Solutions
- 12.4.1 Univar Solutions Company Information
- 12.4.2 Univar Solutions Business Overview
- 12.4.3 Univar Solutions Revenue in Wilson's Disease Business (2021-2026)
- 12.4.4 Univar Solutions Wilson's Disease Product Portfolio
- 12.4.5 Univar Solutions Recent Developments
- 12.5 MSN Laboratories
- 12.5.1 MSN Laboratories Company Information
- 12.5.2 MSN Laboratories Business Overview
- 12.5.3 MSN Laboratories Revenue in Wilson's Disease Business (2021-2026)
- 12.5.4 MSN Laboratories Wilson's Disease Product Portfolio
- 12.5.5 MSN Laboratories Recent Developments
- 12.6 ANI Pharmaceuticals
- 12.6.1 ANI Pharmaceuticals Company Information
- 12.6.2 ANI Pharmaceuticals Business Overview
- 12.6.3 ANI Pharmaceuticals Revenue in Wilson's Disease Business (2021-2026)
- 12.6.4 ANI Pharmaceuticals Wilson's Disease Product Portfolio
- 12.6.5 ANI Pharmaceuticals Recent Developments
- 12.7 APOTEX
- 12.7.1 APOTEX Company Information
- 12.7.2 APOTEX Business Overview
- 12.7.3 APOTEX Revenue in Wilson's Disease Business (2021-2026)
- 12.7.4 APOTEX Wilson's Disease Product Portfolio
- 12.7.5 APOTEX Recent Developments
- 12.8 Tsumura
- 12.8.1 Tsumura Company Information
- 12.8.2 Tsumura Business Overview
- 12.8.3 Tsumura Revenue in Wilson's Disease Business (2021-2026)
- 12.8.4 Tsumura Wilson's Disease Product Portfolio
- 12.8.5 Tsumura Recent Developments
- 12.9 Sinepharm
- 12.9.1 Sinepharm Company Information
- 12.9.2 Sinepharm Business Overview
- 12.9.3 Sinepharm Revenue in Wilson's Disease Business (2021-2026)
- 12.9.4 Sinepharm Wilson's Disease Product Portfolio
- 12.9.5 Sinepharm Recent Developments
- 12.10 Taj Pharmaceutical
- 12.10.1 Taj Pharmaceutical Company Information
- 12.10.2 Taj Pharmaceutical Business Overview
- 12.10.3 Taj Pharmaceutical Revenue in Wilson's Disease Business (2021-2026)
- 12.10.4 Taj Pharmaceutical Wilson's Disease Product Portfolio
- 12.10.5 Taj Pharmaceutical Recent Developments
- 12.11 Kadmon Holdings
- 12.11.1 Kadmon Holdings Company Information
- 12.11.2 Kadmon Holdings Business Overview
- 12.11.3 Kadmon Holdings Revenue in Wilson's Disease Business (2021-2026)
- 12.11.4 Kadmon Holdings Wilson's Disease Product Portfolio
- 12.11.5 Kadmon Holdings Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst